1167 related articles for article (PubMed ID: 9727060)
1. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
2. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
3. Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha.
Liao H; Hyman MC; Lawrence DA; Pinsky DJ
FASEB J; 2007 Mar; 21(3):935-49. PubMed ID: 17197388
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.
Barazzone C; Belin D; Piguet PF; Vassalli JD; Sappino AP
J Clin Invest; 1996 Dec; 98(12):2666-73. PubMed ID: 8981909
[TBL] [Abstract][Full Text] [Related]
5. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
Bator JM; Cohen RL; Chambers DA
Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
[TBL] [Abstract][Full Text] [Related]
6. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.
Kwieciński J; Josefsson E; Jin T
Inflamm Res; 2011 Nov; 60(11):1021-9. PubMed ID: 21786185
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
Kauhanen P; Sirén V; Carpén O; Vaheri A; Lepäntalo M; Lassila R
Circulation; 1997 Sep; 96(6):1783-9. PubMed ID: 9323062
[TBL] [Abstract][Full Text] [Related]
9. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
10. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
11. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
13. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
14. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.
Lawson CA; Yan SD; Yan SF; Liao H; Zhou YS; Sobel J; Kisiel W; Stern DM; Pinsky DJ
J Clin Invest; 1997 Apr; 99(7):1729-38. PubMed ID: 9120018
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
[TBL] [Abstract][Full Text] [Related]
16. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
Cao YJ; Wu YH; Liu CF
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
18. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
Idell S
Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
[TBL] [Abstract][Full Text] [Related]
19. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
Lundgren CH; Sawa H; Sobel BE; Fujii S
Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice.
Okada K; Fujita T; Minamoto K; Liao H; Naka Y; Pinsky DJ
J Biol Chem; 2000 Jul; 275(28):21468-76. PubMed ID: 10806208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
